Absorption and Systematic Pharmacokinetics of IDP-123 Lotion in Comparison With Tazorac Cream
NCT02849873 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 48
Last updated 2018-07-19
Summary
The Absorption and Systematic Pharmacokinetics of IDP-123 Lotion in Comparison with Tazorac Cream.
Conditions
Interventions
- DRUG
-
IDP-123 Lotion
Lotion
- DRUG
-
Tazorac Cream
Cream
Sponsors & Collaborators
-
Bausch Health Americas, Inc.
lead INDUSTRY
Principal Investigators
-
Anya Loncaric · Valeant Pharmaceuticals
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 9 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-06-30
- Primary Completion
- 2016-12-31
- Completion
- 2017-01-31
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A Study Comparing the Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris
NCT02537483 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (301)
NCT03168321 ·Status: COMPLETED ·Phase: PHASE3
-
Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP-126 Gel in Comparison With Control Gel
NCT03653403 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris
NCT02932306 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Safety and Local Tolerability of DFD-03 (Tazarotene) Lotion, 0.1% Compared to Tazorac® Cream, 0.1% in the Topical Treatment of Acne Vulgaris
NCT03341910 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability and Pharmacokinetics of AGN-190168 in Subjects With Acne Vulgaris
NCT02218034 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (302)
NCT03168334 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris
NCT03003247 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris
NCT00666900 ·Status: COMPLETED ·Phase: PHASE2
-
The Use of Teledermatology in the Treatment of Patients With Severe Acne on Isotretinoin
NCT03707236 ·Status: WITHDRAWN ·Phase: NA
-
A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO Wash
NCT00891982 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Tazarotene Cream 0.1% Compared With Adapalene Gel 0.3% in the Treatment of Moderate to Severe Facial Acne Vulgaris
NCT00829049 ·Status: TERMINATED ·Phase: PHASE4
-
Dapsone Gel 5% and Tretinoin Gel 0.025% Versus Tretinoin Gel 0.025% Monotherapy for Facial Acne Vulgaris
NCT00835198 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in Acne
NCT01425320 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects With Acne Vulgaris
NCT01019603 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris
NCT02965456 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety Profile, and Post-Acne Sequelae of 0.025% Retinoic Acid Cream vs. 0.1% Adapalene Cream in Mild Acne Vulgaris in Fitzpatrick Skin Types III-V
NCT07015931 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris
NCT03170388 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Compare Efficacy and Safety of Trifarotene Cream When Used With an Oral Antibiotic for the Treatment of Severe Acne Vulgaris (AV)
NCT04451330 ·Status: COMPLETED ·Phase: PHASE4
-
Dapsone Gel 5% and Tazarotene Cream 0.1% Versus Tazarotene Cream 0.1% Monotherapy for Facial Acne Vulgaris
NCT00834210 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris
NCT02491060 ·Status: UNKNOWN ·Phase: PHASE3
-
Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris
NCT03664739 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Potential of Tazarotene Foam to Cause a Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers
NCT01115322 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris
NCT02535871 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne Vulgaris
NCT02411955 ·Status: COMPLETED ·Phase: PHASE1